v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
| Column | Value |
|---|---|
| Trial registration number | NCT05268185 |
|
Full text link
Last imported at : March 8, 2022, 10:30 p.m. Source : ClinicalTrials.gov |
|
|
First author
Last imported at : March 8, 2022, 10:30 p.m. Source : ClinicalTrials.gov |
|
|
Contact
Last imported at : March 8, 2022, 10:30 p.m. Source : ClinicalTrials.gov |
Not reported |
|
Registration date
Last imported at : March 8, 2022, 10:30 p.m. Source : ClinicalTrials.gov |
2022-03-07 |
|
Recruitment status
Last imported at : Feb. 4, 2023, 8 p.m. Source : ClinicalTrials.gov |
Completed |
|
Study design
Last imported at : March 8, 2022, 10:30 p.m. Source : ClinicalTrials.gov |
RCT |
|
Allocation
Last imported at : March 8, 2022, 10:30 p.m. Source : ClinicalTrials.gov |
Randomized |
|
Design
Last imported at : March 8, 2022, 10:30 p.m. Source : ClinicalTrials.gov |
Parallel |
|
Masking
Last imported at : March 8, 2022, 10:30 p.m. Source : ClinicalTrials.gov |
Open label |
|
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
single-center |
|
Study aim
Last imported at : March 8, 2022, 10:30 p.m. Source : ClinicalTrials.gov |
Prevention |
|
Inclusion criteria
Last imported at : March 8, 2022, 10:30 p.m. Source : ClinicalTrials.gov |
inclusion criteria: must be enrolled in the covid19 citizen science (ccs) study. the ccs study is a remote, longitudinal, observational registry hosted on the eureka research platform that administers weekly questionnaires to participants regarding covid-19 symptoms and exposures. ccs is currently open to enrollment for adults aged 18 and older who have a smartphone device to participate on the mobile app, or an email address to participate on the web portal. must have received either 2 doses of mrna vaccine such as moderna and pfizer, or 1 dose of johnson and johnson |
|
Exclusion criteria
Last imported at : March 8, 2022, 10:30 p.m. Source : ClinicalTrials.gov |
already received a covid19 booster are not planning on receiving a covid19 booster in the next 3 months do not have equal access to both the pfizer and moderna boosters have a medical reason to receive either the pfizer or moderna booster have a medical reason to not receive any booster (e.g h/o allergic reaction to an mrna vaccine or myocarditis or pericarditis after an mrna vaccine) are unwilling to be randomized are unable to commit to filling out the ccs weekly surveys consistently (to the best of their ability) |
|
Number of arms
Last imported at : March 8, 2022, 10:30 p.m. Source : ClinicalTrials.gov |
2 |
|
Funding
Last imported at : March 8, 2022, 10:30 p.m. Source : ClinicalTrials.gov |
University of California, San Francisco |
|
Inclusion age min
Last imported at : March 8, 2022, 10:30 p.m. Source : ClinicalTrials.gov |
18 |
|
Inclusion age max
Last imported at : March 8, 2022, 10:30 p.m. Source : ClinicalTrials.gov |
100 |
|
Countries
Last imported at : March 8, 2022, 10:30 p.m. Source : ClinicalTrials.gov |
United States |
|
Type of patients
Last imported at : March 8, 2022, 10:30 p.m. Source : ClinicalTrials.gov |
Healthy volunteers |
|
Severity scale
Last imported at : March 8, 2022, 10:30 p.m. Source : ClinicalTrials.gov |
N/A |
|
Total sample size
Last imported at : Oct. 17, 2022, 12:34 p.m. Source : ClinicalTrials.gov |
301 |
|
primary outcome
Last imported at : March 8, 2022, 10:30 p.m. Source : ClinicalTrials.gov |
Post-Vaccine Differences in Severity of Symptoms between Homologous vs Heterologous Regiments;Post-Vaccine Differences in Severity of Symptoms between Pfizer and Moderna;Post-Vaccine Differences in Types of Symptoms between Homologous vs Heterologous Regiments;Post-Vaccine Differences in Types of Symptoms between Pfizer and Moderna |
|
Notes
Last imported at : March 8, 2022, 10:30 p.m. Source : ClinicalTrials.gov |
None |
|
Phase
Last imported at : March 8, 2022, 10:30 p.m. Source : ClinicalTrials.gov |
Not reported |
|
Arms
Last imported at : March 8, 2022, 10:30 p.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 824, "treatment_name": "Mrna-1273", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "", "treatment_id": 222, "treatment_name": "Bnt162b2", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}] |